Recent Progress in Exosome-Derived Nanocarriers for Breast Cancer Therapy: Advances, Translational Barriers, and Scale-Up Considerations.

Saved in:
Bibliographic Details
Title: Recent Progress in Exosome-Derived Nanocarriers for Breast Cancer Therapy: Advances, Translational Barriers, and Scale-Up Considerations.
Authors: Youssef JR; Pharmaceutics Department, College of Pharmacy, Arab Academy for Science, Technology and Maritime Transport (AASTMT), Alamein, Egypt., Elgammal EM; College of Pharmacy, Arab Academy for Science, Technology and Maritime Transport (AASTMT), Alamein, Egypt., Mahdy DM; Pharmaceutics Department, College of Pharmacy, Arab Academy for Science, Technology and Maritime Transport (AASTMT), Alamein, Egypt., Ghazi NF; Pharmaceutics Department, Faculty of Pharmacy, Mansoura University, Dakahlyia, Egypt., Bebawy G; Pharmaceutics Department, Faculty of Pharmacy, Alexandria University, 1 Khartoum Square, Alexandria, Azarita, Egypt. George.bebawy@alexu.edu.eg.
Source: Pharmaceutical research [Pharm Res] 2026 Jun; Vol. 43 (6), pp. 1935-1977. Date of Electronic Publication: 2026 Apr 21.
Publication Type: Journal Article; Review
Journal Info: Publisher: Kluwer Academic/Plenum Publishers Country of Publication: United States NLM ID: 8406521 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-904X (Electronic) Linking ISSN: 07248741 NLM ISO Abbreviation: Pharm Res Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1573-904X
DOI:10.1007/s11095-026-04095-3